Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018, Article ID 8283648, 9 pages
https://doi.org/10.1155/2018/8283648
Review Article

Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine

1Department of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden
2Department of Medicine-Cardiology, Karolinska Institutet, 171 77 Stockholm, Sweden

Correspondence should be addressed to Makoto Sahara; es.ik@arahas.otokam

Received 9 August 2017; Revised 29 November 2017; Accepted 25 December 2017; Published 5 February 2018

Academic Editor: Fatemeh Sharifpanah

Copyright © 2018 Nevin Witman and Makoto Sahara. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Caspi, I. Huber, I. Kehat et al., “Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts,” Journal of the American College of Cardiology, vol. 50, no. 19, pp. 1884–1893, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Qian, Y. Huang, C. I. Spencer et al., “In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes,” Nature, vol. 485, no. 7400, pp. 593–598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Sanganalmath and R. Bolli, “Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions,” Circulation Research, vol. 113, no. 6, pp. 810–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. M. Monteiro, F. Vasques-Nóvoa, L. Ferreira, P. Pinto-do-Ó, and D. S. Nascimento, “Restoring heart function and electrical integrity: closing the circuit,” npj Regenerative Medicine, vol. 2, no. 1, p. 9, 2017. View at Publisher · View at Google Scholar
  5. A. Mauretti, S. Spaans, N. A. M. Bax, C. Sahlgren, and C. V. C. Bouten, “Cardiac progenitor cells and the interplay with their microenvironment,” Stem Cells International, vol. 2017, Article ID 7471582, 20 pages, 2017. View at Publisher · View at Google Scholar
  6. M. Sahara, F. Santoro, and K. R. Chien, “Programming and reprogramming a human heart cell,” The EMBO Journal, vol. 34, no. 6, pp. 710–738, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Tzahor and K. D. Poss, “Cardiac regeneration strategies: staying young at heart,” Science, vol. 356, no. 6342, pp. 1035–1039, 2017. View at Publisher · View at Google Scholar
  8. A. Moretti, L. Caron, A. Nakano et al., “Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification,” Cell, vol. 127, no. 6, pp. 1151–1165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Wu, Y. Fujiwara, S. M. Cibulsky et al., “Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart,” Cell, vol. 127, no. 6, pp. 1137–1150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Brade, L. S. Pane, A. Moretti, K. R. Chien, and K. L. Laugwitz, “Embryonic heart progenitors and cardiogenesis,” Cold Spring Harbor Perspectives in Medicine, vol. 3, no. 10, p. a013847, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Liang, G. Wang, L. Lin et al., “HCN4 dynamically marks the first heart field and conduction system precursors,” Circulation Research, vol. 113, no. 4, pp. 399–407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Später, M. K. Abramczuk, K. Buac et al., “A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells,” Nature Cell Biology, vol. 15, no. 9, pp. 1098–1106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. C. L. Cai, X. Liang, Y. Shi et al., “Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart,” Developmental Cell, vol. 5, no. 6, pp. 877–889, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Bu, X. Jiang, S. Martin-Puig et al., “Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages,” Nature, vol. 460, no. 7251, pp. 113–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. K. L. Laugwitz, A. Moretti, J. Lam et al., “Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages,” Nature, vol. 433, no. 7026, pp. 647–653, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Noseda, T. Peterkin, F. C. Simoes, R. Patient, and M. D. Schneider, “Cardiopoietic factors: extracellular signals for cardiac lineage commitment,” Circulation Research, vol. 108, no. 1, pp. 129–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. L. Cai, J. C. Martin, Y. Sun et al., “A myocardial lineage derives from Tbx18 epicardial cells,” Nature, vol. 454, no. 7200, pp. 104–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Zhou, Q. Ma, S. Rajagopal et al., “Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart,” Nature, vol. 454, no. 7200, pp. 109–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. C. Katz, M. K. Singh, K. Degenhardt et al., “Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells,” Developmental Cell, vol. 22, no. 3, pp. 639–650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. R. Hutson and M. L. Kirby, “Model systems for the study of heart development and disease: cardiac neural crest and conotruncal malformations,” Seminars in Cell & Developmental Biology, vol. 18, no. 1, pp. 101–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Hildreth, S. Webb, L. Bradshaw, N. A. Brown, R. H. Anderson, and D. J. Henderson, “Cells migrating from the neural crest contribute to the innervation of the venous pole of the heart,” Journal of Anatomy, vol. 212, no. 1, pp. 1–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. P. Beltrami, L. Barlucchi, D. Torella et al., “Adult cardiac stem cells are multipotent and support myocardial regeneration,” Cell, vol. 114, no. 6, pp. 763–776, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. J. H. Chong, E. Forte, and R. P. Harvey, “Developmental origins and lineage descendants of endogenous adult cardiac progenitor cells,” Stem Cell Research, vol. 13, no. 3, pp. 592–614, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Bearzi, M. Rota, T. Hosoda et al., “Human cardiac stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14068–14073, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. G. M. Ellison, C. Vicinanza, A. J. Smith et al., “Adult c-kitpos cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair,” Cell, vol. 154, no. 4, pp. 827–842, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. H. van Berlo, O. Kanisicak, M. Maillet et al., “c-kit+ cells minimally contribute cardiomyocytes to the heart,” Nature, vol. 509, no. 7500, pp. 337–341, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Smith, F. C. Lewis, I. Aquila et al., “Isolation and characterization of resident endogenous c-kit+ cardiac stem cells from the adult mouse and rat heart,” Nature Protocols, vol. 9, no. 7, pp. 1662–1681, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Fazel, M. Cimini, L. Chen et al., “Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1865–1877, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Vicinanza, I. Aquila, M. Scalise et al., “Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification,” Cell Death & Differentiation, vol. 24, no. 12, pp. 2101–2116, 2017. View at Publisher · View at Google Scholar
  30. K. U. Hong, Y. Guo, Q. H. Li et al., “c-kit+ cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart,” PLoS One, vol. 9, no. 5, article e96725, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. L. Torán, S. Aguilar, J. A. López et al., “CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretome,” Scientific Reports, vol. 7, no. 1, article 12490, 2017. View at Publisher · View at Google Scholar
  32. J. J. H. Chong, H. Reinecke, M. Iwata, B. Torok-Storb, A. Stempien-Otero, and C. E. Murry, “Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart,” Stem Cells and Development, vol. 22, no. 13, pp. 1932–1943, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. J. Kattman, T. L. Huber, and G. M. Keller, “Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages,” Developmental Cell, vol. 11, no. 5, pp. 723–732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. S. J. Kattman, A. D. Witty, M. Gagliardi et al., “Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines,” Cell Stem Cell, vol. 8, no. 2, pp. 228–240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Yang, M. H. Soonpaa, E. D. Adler et al., “Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population,” Nature, vol. 453, no. 7194, pp. 524–528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Matsuura, T. Nagai, N. Nishigaki et al., “Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes,” The Journal of Biological Chemistry, vol. 279, no. 12, pp. 11384–11391, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Oh, S. B. Bradfute, T. D. Gallardo et al., “Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12313–12318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Messina, L. De Angelis, G. Frati et al., “Isolation and expansion of adult cardiac stem cells from human and murine heart,” Circulation Research, vol. 95, no. 9, pp. 911–921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. C. M. Martin, A. P. Meeson, S. M. Robertson et al., “Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart,” Developmental Biology, vol. 265, no. 1, pp. 262–275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. D. M. DeLaughter, A. G. Bick, H. Wakimoto et al., “Single-cell resolution of temporal gene expression during heart development,” Developmental Cell, vol. 39, no. 4, pp. 480–490, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Jain, D. Li, M. Gupta et al., “Integration of Bmp and Wnt signaling by Hopx specifies commitment of cardiomyoblasts,” Science, vol. 348, no. 6242, article aaa6071, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Bardot, D. Calderon, F. Santoriello et al., “Foxa2 identifies a cardiac progenitor population with ventricular differentiation potential,” Nature Communications, vol. 8, article 14428, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Ishida, R. Saba, I. Kokkinopoulos et al., “GFRA2 identifies cardiac progenitors and mediates cardiomyocyte differentiation in a RET-independent signaling pathway,” Cell Reports, vol. 16, no. 4, pp. 1026–1038, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Birket, M. C. Ribeiro, A. O. Verkerk et al., “Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells,” Nature Biotechnology, vol. 33, no. 9, pp. 970–979, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. P. A. Lalit, M. R. Salick, D. O. Nelson et al., “Lineage reprogramming of fibroblasts into proliferative induced cardiac progenitor cells by defined factors,” Cell Stem Cell, vol. 18, no. 3, pp. 354–367, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Witman and M. Sahara, “Expansion of cardiac progenitors from reprogrammed fibroblasts as potential novel cardiovascular therapy,” Stem Cell Investigation, vol. 3, p. 34, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Zhang, N. Cao, Y. Huang et al., “Expandable cardiovascular progenitor cells reprogrammed from fibroblasts,” Cell Stem Cell, vol. 18, no. 3, pp. 368–381, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Fernandes, J. J. H. Chong, S. L. Paige et al., “Comparison of human embryonic stem cell-derived cardiomyocytes, cardiovascular progenitors, and bone marrow mononuclear cells for cardiac repair,” Stem Cell Reports, vol. 5, no. 5, pp. 753–762, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. A. R. Khan, T. A. Farid, A. Pathan et al., “Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis,” Circulation Research, vol. 118, no. 6, pp. 984–993, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Hao, R. Wang, and W. Wang, “Cell therapies in cardiomyopathy: current status of clinical trials,” Analytical Cellular Pathology, vol. 2017, Article ID 9404057, 20 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Bolli, A. R. Chugh, D. D'Amario et al., “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial,” The Lancet, vol. 378, no. 9806, pp. 1847–1857, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. A. N. Nowbar, M. Mielewczik, M. Karavassilis et al., “Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis,” BMJ, vol. 348, apr28 1, p. g2688, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., “Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial,” Journal of the American Medical Association, vol. 308, no. 22, pp. 2369–2379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Karantalis, D. L. DiFede, G. Gerstenblith et al., “Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial,” Circulation Research, vol. 114, no. 8, pp. 1302–1310, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. I. Chimenti, R. Gaetani, L. Barile et al., “Isolation and expansion of adult cardiac stem/progenitor cells in the form of cardiospheres from human cardiac biopsies and murine hearts,” Methods in Molecular Biology, vol. 879, pp. 327–338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Malliaras, R. R. Makkar, R. R. Smith et al., “Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction),” Journal of the American College of Cardiology, vol. 63, no. 2, pp. 110–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. M. H. Yacoub and J. Terrovitis, “CADUCEUS, SCIPIO, ALCADIA: cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving,” Global Cardiology Science & Practice, vol. 2013, no. 1, pp. 3–8, 2013. View at Publisher · View at Google Scholar
  58. P. W. Burridge, E. Matsa, P. Shukla et al., “Chemically defined generation of human cardiomyocytes,” Nature Methods, vol. 11, no. 8, pp. 855–860, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. C. E. Murry and G. Keller, “Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development,” Cell, vol. 132, no. 4, pp. 661–680, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Xi, M. Khalil, N. Shishechian et al., “Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells,” The FASEB Journal, vol. 24, no. 8, pp. 2739–2751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. J. J. H. Chong, X. Yang, C. W. Don et al., “Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts,” Nature, vol. 510, no. 7504, pp. 273–277, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Shiba, S. Fernandes, W. Z. Zhu et al., “Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts,” Nature, vol. 489, no. 7415, pp. 322–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Shiba, D. Filice, S. Fernandes et al., “Electrical integration of human embryonic stem cell-derived cardiomyocytes in a guinea pig chronic infarct model,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 19, no. 4, pp. 368–381, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. X. L. Tang, G. Rokosh, S. K. Sanganalmath et al., “Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction,” Circulation, vol. 121, no. 2, pp. 293–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Bolli, X. L. Tang, S. K. Sanganalmath et al., “Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy,” Circulation, vol. 128, no. 2, pp. 122–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Cimetta, A. Godier-Furnemont, and G. Vunjak-Novakovic, “Bioengineering heart tissue for in vitro testing,” Current Opinion in Biotechnology, vol. 24, no. 5, pp. 926–932, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. M. N. Hirt, A. Hansen, and T. Eschenhagen, “Cardiac tissue engineering: state of the art,” Circulation Research, vol. 114, no. 2, pp. 354–367, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Tachibana, M. R. Santoso, M. Mahmoudi et al., “Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium,” Circulation Research, vol. 121, no. 6, pp. e22–e36, 2017. View at Publisher · View at Google Scholar
  69. M. Ieda, J. D. Fu, P. Delgado-Olguin et al., “Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors,” Cell, vol. 142, no. 3, pp. 375–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Song, Y. J. Nam, X. Luo et al., “Heart repair by reprogramming non-myocytes with cardiac transcription factors,” Nature, vol. 485, no. 7400, pp. 599–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Yamakawa and M. Ieda, “Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming,” International Heart Journal, vol. 56, no. 1, pp. 1–5, 2015. View at Publisher · View at Google Scholar